17-241 Phase I
A Phase 1/2 Study of Oral LOXO-292 in Patients with Advanced Solid Tumors, Including RET Fusion-Positive Solid Tumors, Medullary Thyroid Cancer, and Other Tumors with RET Activation (LIBRETTO-001) (View details on clinicaltrial.gov)
Search Cancer Clinical Trials
The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
4 results
17-481 Phase II
A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects with Previously Treated NTRK Fusion Cancers (View details on clinicaltrial.gov)
19-804 Phase II
A phase 1/2 study of TPX-0046,a novel oral RET/SRC inhibitor in adult subjects with advanced/metastatic solid tumors harboring oncogenic RET fusions or mutations (View details on clinicaltrial.gov)
16-616 Phase II
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers (View details on clinicaltrial.gov)
Showing 1 - 10 of 4 results